Key result
Discontinuing colchicine and atorvastatin resolves rhabdomyolysis linked to their combined use.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Colchicine can induce severe rhabdomyolysis, particularly when used concomitantly with statins, requiring prompt recognition and discontinuation of the offending agents.
A 74-year-old man with medical history significant for atrial fibrillation, hyperlipidaemia and coronary artery disease on atorvastatin presented to the emergency department with profound weakness. The patient reports he first noticed his weakness 4 weeks after starting colchicine, prescribed for recurrent pericarditis with pericardial effusion, a complication following recent coronary artery bypass grafting. The patient was also on prednisone therapy for presumed post-pericardiotomy syndrome. The weakness involved all four limbs but was more notable in the lower extremities, with preserved sensation and tenderness to palpation. Labs showed an elevated creatinine phosphokinase and serum creatinine consistent with rhabdomyolysis. Discontinuation of the offending medications, including colchicine and atorvastatin, as well as intravenous fluid resuscitation with physical rehabilitation, led to improvement in the patient's symptoms. He was eventually discharged to a rehabilitation facility to continue physical therapy.
No takes yet. Share an insight, caveat, or question.
Abudalou et al. (2021) conducted a case report in Colchicine-induced rhabdomyolysis (n=1). Colchicine was evaluated on Development of rhabdomyolysis and symptom improvement upon discontinuation. Discontinuation of colchicine and atorvastatin led to clinical improvement in a 74-year-old man who developed rhabdomyolysis 4 weeks after starting colchicine.
Synapse has enriched 10 related papers. Consider them for comparative context: